← Back to patent-cliff list
IVMED-85
Tier C — Watch / tradeIVMED-85
iVeena Delivery Systems Inc
Originator
-
First approval
-
Expiry (public)
No sales data
Peak sales
Small molecule
Type
Targets：Lysyl oxidase
Indications (approved)：变性近视, 近视
Regional status
US
Phase I
2026-02-04
EU
-
China
-
Japan
-
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of IVMED-85?
Approved indications include: 变性近视, 近视.
When does the IVMED-85 patent expire?
No public expiry year is available for IVMED-85 yet; this page updates once verified.
How do I get a quote for IVMED-85 intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-10-02